Home » Newsletters » BioWorld Science

BioWorld Science

June 13, 2013

View Archived Issues

Phase III evaluation of a polymerase inhibitor for the treatment of drug-resistant hepatitis C

First-in-human results presented for the imaging agent [18F]FC-119S

Researchers at Biota Scientific Management present new antiviral agents

Hereditary fibrosing poikiloderma, a new condition caused by FAM111B gene mutations

Novel biomarker associated with suicide attempt in patients with MDD

Pfizer presents phase I results for a novel biosimilar of trastuzumab

Ocriplasmin receives initial recommendation for NHS reimbursement in U.K.

NeuroVive Pharmaceutical reports new collaboration and milestone payment from Sihuan

Natural derived polymer VS-501 may control serum phosphate in CKD

Derma Sciences reports data from pharmacokinetic study of DSC-127

Amgen and Cytokinetics expand license for omecamtiv mecarbil

Teprotumumab to be developed in new indication

Aphios and VivaCell to develop non-psychotropic cannabinoids

Ferrer completes phase III trial of ozenoxacin in impetigo

Roche presents new CB2 receptor agonists

Amgen reports topline results from phase III TRINOVA-1 trial

Constellation Pharmaceuticals prepares new EZH2 inhibitors for cancer

Chinese researchers patent novel HIV fusion inhibitors

Bioheart completes phase I ANGEL study

New DHODH inhibitors for malaria presented by Chinese researchers

Funding supports Madera's development of small-molecule drugs for Alzheimer's disease

Bill & Melinda Gates Foundation and European Commission partner

Nanobiotix cleared to begin study of NBTXR-3 for head and neck cancer

Exact Sciences completes PMA application for Cologuard screening test

Constella launched in Europe for the treatment of IBS-C

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...
Cancer specter looming, Abtect effect in UC wallops Abivax
BioWorld
Although analysts liked the data – calling them “truly amazing” and “transformational” – Wall Street apparently had qualms about three cancer cases that turned up...
EASL spotlight: TUNE-401 advances epigenetic silencing in HBV
BioWorld
Several presentations at EASL highlight a new generation of therapies coming into view, with the work from Tune Therapeutics Inc. standing out as one of the most...